nassau to look into infections tied to doctor

New York Times Nassau to Look Into Infections Tied to Doctor Paul Vitello
November 22, 2007

The Nassau County district attorney, Kathleen Rice, said yesterday that she would investigate "the entirety of the circumstances" that led a patient to be infected with hepatitis C and hundreds more to be placed at risk by the improper infection-control practices of an anesthesiologist on Long Island. Through a spokesman, Eric Phillips, Ms. Rice declined to say whether criminal charges might be considered against the anesthesiologist, Dr. Harvey S. Finkelstein. "Given the urgent need to identify exactly what happened and to fully understand the scope of the possible threat, the district attorney made the decision to launch an immediate investigation," Mr. Phillips said. Neither Dr. Finkelstein nor his spokesman replied to messages yesterday requesting comment. On Nov. 10, the State Health Department notified 628 of Dr. Finkelstein's patients that they might have been exposed to hepatitis C, hepatitis B, or H.I.V. from 2000 to 2005, as a result of Dr. Finkelstein's improper reuse of syringes in his clinic, which specializes in pain management. The department first confirmed the problem in January 2005 but took 34 months to notify patients. The state health commissioner, Richard F. Daines, has recommended that anyone who received an injection from Dr. Finkelstein in his private practice, which began in the 1980s, should be tested for the two types of hepatitis and H.I.V. The recommendation came after hundreds of current and former patients contacted health authorities to ask if they should be tested. So far, hundreds of patients have had the blood tests; one had a positive result for hepatitis B, though health officials said further tests were needed to determine whether it was connected to Dr. Finkelstein's work. In January 2005, State Health Department epidemiologists traced the transmission of a hepatitis C infection to his private clinic in Plainview. Dr. Finkelstein's case was reviewed by the Office of Professional Medical Conduct, but by the time the review took place, Dr. Finkelstein had changed his methods to comply with standard practice.

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 OHIO: Phila Health Department HIV Testing Well-Received CONNECTICUT: City's Circle Care Center is a Model for HIV Prevention UNITED STATES: New Compound Excels at Killing Persistent and Drug-Resistant Tuberculosis INDIA: India Faces TB Drug Shortage, Warns International Medical Org ALASKA: After Topping List for Chlamydia Rates, Alaska Seeing Some Improvement Tanzania: Police Abuse, Torture, Impede HIV Services Growing HIV/AIDS awareness in Indonesia's Papua region South Africa: Catastrophe as Eastern Cape drug stock-outs continue Community-led programmes critical to progress on AIDS in Sri Lanka One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs AHF: Porn Industry Says Condoms Limited Spread of Latest Adult Film HIV Infection Study: AIDS Drug Cuts Infections Among Drug Users Medication Stops HIV Infection of Drug Users ABL Acquires Evivar Medical Assets and Further Enhances its IT Solutions and Personalized Healthcare Platform for Hepatitis B, Hepatitis C and HIV Infections HIV regimen prevents infection among drug users GLOBAL: The 'Elastic Band' Circumcision Device that could Reduce HIV Infection Rate by 60% BRITISH COLUMBIA: Syphilis Infection Rates in B.C. Almost Double in 2012 European Commission Approves Stribild®, a New Single Tablet Regimen for the Treatment of HIV-1 Infection European Commission Approves Stribild®, a New Single Tablet Regimen for the Treatment of HIV-1 Infection UNITED STATES: An Urban Challenge: Diagnosing and Treating Latent Tuberculosis Infection
Copyright © 2007 -New York Times, Publisher. All rights reserved to New York Times company. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only. Information in this article was accurate in November 22, 2007. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.